Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/01/2012EP2410858A1 P2x3 receptor antagonists for treatment of pain
02/01/2012EP2410857A1 P2x3, receptor antagonists for treatment of pain
02/01/2012EP2410856A1 Diaminopteridine derivatives
02/01/2012EP2410855A1 Process for the preparation of alogliptin
02/01/2012EP2410846A1 Glycolipids as treatment for disease
02/01/2012EP2410844A1 Inhibitors of hepatitis c virus replication
02/01/2012EP2410843A1 Fused ring inhibitors of hepatitis c
02/01/2012EP2410841A1 Substituted bicyclic hcv inhibitors
02/01/2012EP2331546B1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof
02/01/2012EP2268626B1 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of hsp90 chaperone and the intermediates for production thereof
02/01/2012EP2265601B1 Pyridazine derivatives as factor xia inhibitors
02/01/2012EP2228063B1 Loxoprofen-containing aqueous plaster
02/01/2012EP2212287B1 PIPERIDINYL AND PIPERAZINYL MODULATORS OF y-SECRETASE
02/01/2012EP2190426B1 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
02/01/2012EP2188297B1 Pyrrolo [2,1-c][1, 4] benzodiazepine-glycoside prodrugs useful as a selective anti tumor agent
02/01/2012EP2132174B1 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
02/01/2012EP2107907B1 Combination of pemirolast and ramatroban for use in the treatment of inflammatory disorders
02/01/2012EP2099793B1 Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase
02/01/2012EP2094260B1 Treatment of lung cancer
02/01/2012EP2081910B1 Novel compounds
02/01/2012EP2079735B1 N- (2 -hydroxyethyl) -n-methyl- 4- (quinolin- 8-yl (1- (thiazol-4- ylmethyl) piperidin- 4 -ylidene) methyl) benzamide, the process of making it as well as its use for the treatment of pain, anxiety and depression.
02/01/2012EP2066319B1 Benzotriazole kinase modulators
02/01/2012EP2064204B1 Inhibitors of 5 -lipoxygenase activating protein ( flap)
02/01/2012EP2062576B1 Adhesive preparation comprising desglymidodrine
02/01/2012EP2049475B1 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
02/01/2012EP2041123B1 Fused cyclic compounds
02/01/2012EP2037925B1 Combinations comprising 5ht6 modulators and cholinesterase inhibitors
02/01/2012EP1953165B1 Aza-substituted spiro derivative
02/01/2012EP1951225B1 3-acylindole derivatives the preparation and the therapeutic use thereof
02/01/2012EP1942895B1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
02/01/2012EP1940385B1 Pharmaceutical composition having a ruthenium oxalato compound and method of using the same
02/01/2012EP1937669B1 Novel benzopyran derivatives as potassium channel openers
02/01/2012EP1934176B1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
02/01/2012EP1888595B1 Spiro-oxindole compounds and their uses as therapeutic agents
02/01/2012EP1848719B1 [1h-pyrazolo[3,4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-threonine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases
02/01/2012EP1833794B1 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
02/01/2012EP1817301B1 Potentiators of glutamate receptors
02/01/2012EP1781277B1 A combination composition comprising ibuprofen and paracetamol
02/01/2012EP1699925B1 DCRS5 and p19 antagonists for therapy of asthma, allergy and COPD
02/01/2012EP1654231B1 Conjugate compounds and methods for reducing the risk of epileptic occurrence or for treatment of seizure disorders
02/01/2012EP1652848B1 Process for producing imide compound
02/01/2012EP1531810B1 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
02/01/2012EP1511725B1 24-sulfoximine vitamin d3 compounds
02/01/2012EP1353699B1 Beta-cyclodextrin-drospirenone inclusion complexes
02/01/2012EP1334117B1 Antibacterial agents comprising conjugates of glycopeptides and peptidic membrane-associating elements
02/01/2012EP1286989B1 Prodrug of an ICE inhibitor
02/01/2012CN1951899B 阿司匹林触发的脂质介体 Aspirin-triggered lipid mediators
02/01/2012CN1913917B 凝血酶肽衍生物的药物组合物 The pharmaceutical composition of the thrombin peptide derivative
02/01/2012CN1846694B 取代芳香基双胍类化合物及含它们的药物组合物在制备抗恶性肿瘤药物方面的应用 Biguanide compounds and substituted aromatic group-containing pharmaceutical compositions thereof for the manufacture of anti-cancer drugs
02/01/2012CN1742731B 治疗雌性性机能障碍的吡唑并嘧啶酮类 Treatment of female sexual dysfunction Pyrazolopyrimidine ketones
02/01/2012CN102341498A Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
02/01/2012CN102341402A Thienopyridines as pharmacologically active agents
02/01/2012CN102341400A Pyrrolopyrimidines used as kinase inhibitors
02/01/2012CN102341399A Quinoxaline compounds
02/01/2012CN102341398A Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
02/01/2012CN102341397A Improved chemical synthesis of diazaindoles by chichibabin cyclization
02/01/2012CN102341395A 3h-imidazo [4, 5 -c] pyridine- 6 -carboxamides as anti- inflammatory agents
02/01/2012CN102341394A Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
02/01/2012CN102341393A Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
02/01/2012CN102341392A Novel crystalline hydrate, amorphous and polymorphic forms of dihydro-benzoxazole-6-yl-acetamide derivative and processes for their preparation
02/01/2012CN102341391A Cromolyn derivatives and related methods of imaging and treatment
02/01/2012CN102341388A Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
02/01/2012CN102341386A Pyridine derivative
02/01/2012CN102341385A Piperazine compound capable of inhibiting prostaglandin d synthase
02/01/2012CN102341384A P38 map kinase inhibitors
02/01/2012CN102341383A Inhibitors of Bruton's Tyrosine Kinase
02/01/2012CN102341382A Heterocyclic antiviral compounds
02/01/2012CN102341380A Bumetanide, furosemide, piretanide, azosemide, and torsemide analogs, compositions and methods of use
02/01/2012CN102341379A Derivatives of benzothiazines, preparation thereof and application thereof as drugs
02/01/2012CN102341374A Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators
02/01/2012CN102341373A Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators
02/01/2012CN102341372A Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
02/01/2012CN102341371A Bis aromatic compounds for use as lct4 synthase inhibitors
02/01/2012CN102341166A DISPERSION composition AND MANUFACTURING METHOD THEREFOR
02/01/2012CN102341125A Formulations comprising ceftiofur and ketoprofen or ceftiofur and benzyl alcohol
02/01/2012CN102341124A External preparation containing analgesic/anti-inflammatory agent
02/01/2012CN102341123A External preparation containing analgesic/anti-inflammatory agent
02/01/2012CN102341122A External preparation containing analgesic/anti-inflammatory agent
02/01/2012CN102341110A Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
02/01/2012CN102341109A Medicinal cosmetic lipoatrophy
02/01/2012CN102341108A Phosphoinositide 3-kinase inhibitors with zinc binding moiety
02/01/2012CN102341107A Combination therapies for neoplastic disorders
02/01/2012CN102341106A Compounds and methods for inhibiting mmp2 and mmp9
02/01/2012CN102341105A Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
02/01/2012CN102341104A Pharmaceutical composition containing 1h-inden-1-amine, 2,3-dihydro-n-2-propynyl-, (1r)-, methanesulfonate
02/01/2012CN102341103A Novel Use of Fibrates
02/01/2012CN102341102A Use of pyrimidylaminobenzamide derivatives for treatment of disorders mediated by leucine zipper- and sterile alpha motif-containing kinase (zak)
02/01/2012CN102341099A Sustained release oral dosage forms of an R-baclofen prodrug
02/01/2012CN102341098A Oral dosage forms having high loading of gabapentin prodrug
02/01/2012CN102341096A Abuse resistant formulation
02/01/2012CN102341095A Process for preparation of pharmaceutical composition comprising ezetimibe
02/01/2012CN102341094A Cationic oil-in-water emulsions containing prostaglandins and uses thereof
02/01/2012CN102341093A Anionic oil-in-water emulsions containing prostaglandins and uses thereof
02/01/2012CN102341092A Method of dissolving antifungal agent, and compositions with high concentration of antifungal agent, suitable for application to the nail
02/01/2012CN102341091A Riluzole aqueous suspensions
02/01/2012CN102341008A Covalent milk protein/isothiocyanate complexes
02/01/2012CN102340992A 吡咯烷三重再摄取抑制剂 Pyrrolidine triple reuptake inhibitors
02/01/2012CN102337297A Mbr-FPGS (folylpolyglutamate synthetase) efficient expression vector and construction method and application thereof
02/01/2012CN102336931A Ophiopogonpolysaccharide, and preparation method and application thereof
02/01/2012CN102336904A Multivalent polyglycol (PEG) modifier for camptothecin and derivatives thereof and application of multivalent PEG modifier
1 ... 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 ... 7860